INS and type 2 diabetes mellitus: Our implicit HbA1c method may increase the frequency of sugar monitoring compared to the guideline-suggested 2~3 times of SMBG per week in non-insulin-treated T2DM; the usage of this novel non-invasive glucose monitor technology might help diabetologists to optimize diabetic therapy in the future.